This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Frederick L. Ruben, MD
Pittsburgh, Pa

Arch Intern Med. 1995;155(7):771-772.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The recent article on pneumococcal vaccine published in the ARCHIVES¹ provides an unbalanced viewpoint on the issues of the efficacy and use of pneumococcal vaccine in the United States. The authors omit critical information from their discussion of the literature that would greatly weaken their conclusions regarding who the evidence warrants vaccinating.

In their introduction, Hirschmann and Lipsky state "the only American population tested with a modern vaccine before approval of the Food and Drug Administration was..."¹ and mention the study by Amman et al.² This is incorrect, since the trials at Kaiser-Permanente and Dorothea Dix³ were conducted well before the approval was given in 1977. One can refute the authors' assertion that the studies of MacLeod et al⁴ were not relevant, since these studies used polyvalent purified capsular polysaccharides, virtually identical to the ones in use today, but with fewer serotypes included in the . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?